Edwards Lifesciences Corp

Edwards Lifesciences makes medical devices to treat advanced heart diseases, focusing on transcatheter heart valve replacement (SAPIEN family), valve repair products (PASCAL, EVOQUE), and surgical structural heart solutions (INSPIRIS line) [Company Overview]. They sell through direct sales teams and distributors across the United States, Europe, Japan, and other international markets [Company Overview].

Edwards Lifesciences is a $47.3B medical device company specializing in advanced heart valve replacement and repair products, serving patients with serious cardiovascular diseases [Yahoo Finance]. The company has lagged the S&P 500 significantly over the past year (+7.8% vs. +26.6%), suggesting investor caution despite strong underlying financials [Yahoo Finance]. Recent insider selling activity and a JPMorgan Chase position reduction warrant attention [SEC Form 4] [EODHD].

Edwards is financially robust with excellent margins, zero net debt, and strong cash generation [Yahoo Finance].